PharmaSGP Holding SE

PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance

PharmaSGP Holding SE strengthens the Management Board to further accelerate growth

PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024

PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023

PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024